Prognostic indicators estimated by 99mTc-GSA in acute liver damage

Hepatology Research

Volumn 31, Issue 3, 2005, Pages 153-159

  Monoe, Takashi ^a   Nomura, Tomoyuki ^b   Nakao, Haruhisa ^a,b   Sobue, Satoshi ^a,b   Mizuno, Yaichi ^a,b   Nojiri, Syunsuke ^a,b   Kanematsu, Takayoshi ^a,b   Senda, Katsuhiro ^a,b   Ohmi, Hitoshi ^a,b   Ohara, Hirotaka ^a,b   Joh, Takashi ^a,b   Itoh, Kazuyuki ^a   Itoh, Makoto ^b  

^a Kasugai City Health Care Center   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

99mTc GSA; Acute liver damage; Prognosis

Indexed keywords

HUMAN SERUM ALBUMIN TC 99M; PENTETATE TECHNETIUM TC 99M;

ACUTE HEPATITIS; ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONVALESCENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG CLEARANCE; DRUG UPTAKE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HOSPITAL PATIENT; HUMAN; LIVER DISEASE; LIVER SCINTISCANNING; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL DECISION MAKING; MORTALITY; ORTHOTOPIC TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SURVIVAL; TOXIC HEPATITIS;

EID: 20244388508     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.11.013     Document Type: Article

References (28)

1. S. Mochida K. Fujiwara Recent advances in acute and fulminant hepatitis in Japan Intern. Med. 40 2001 175-177
2. C. Vickers J. Neuberger J. Buckels et al. Transplantation of liver in adults and children with fulminant hepatic failure J. Hepatol. 7 1988 143-150
3. R.R. Peleman J.S. Gavaler D.H. Van Thiel et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults Hepatology 7 1987 484-489
4. H. Matsunami M. Makuuchi S. Kawasaki et al. Living-related liver transplantation in fulminant hepatic failure Lancet 340 1992 1411-1412
5. J.H. Hoofnagle R.L. Carithers C. Shaprio N. Ascher Fulminant hepatic failure: Summary of a workshop Hepatology 21 1995 240-252
6. S. Miwa Y. Hashikura A. Mita et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure Hepatology 30 1999 1521-1526
7. S. Uemoto Y. Inomata T. Sakurai et al. Living donor liver transplantation for fulminant hepatic failure Transplantation 70 2000 152-157
8. J.G. O'Grady G.J.M. Alexander K.M. Hayllar R. Williams Early indicators or prognosis in fulminant hepatic failure Gastroenterology 97 1989 439-445
9. E. Christensen A. Bremmelgaard M. Bahnsen P.B. Andreasen N. Tygstrup Prediction of fatality in fulminant hepatic failure Scand. J. Gastroenterol. 19 1984 90-96
10. P.M. Harrison J.G. O'Grady R.T. Keays G.J.M. Alexander R. Williams Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure Br. Med. J. 301 1990 964-966
11. Y. Takahashi H. Kumada M. Shimizu et al. A multicenter study on the prognosis of fulminant viral hepatitis: Early predication for liver transplantation Hepatology 19 1994 1065-1071
12. Mutoh Y, Ishiki Y, Sugihara J, et al. Fulminant hepatitis in Japan (1992). Intractable Liver Diseases Study Group of Japan, The Ministry of Health and Welfare. Annual Report at 1993. 1994. p. 44-50 (in Japanese).
13. K. Sekiyama M. Yoshiba K. Inoue F. Sugata Prognostic value of hepatic volumetry in fulminant hepatic failure Dig. Dis. Sci. 39 1994 240-244
14. T. Kumahara Y. Muto H. Moriwaki T. Yoshida E. Tomita Determination of the integrated CT number of the whole liver in patients with severe hepatitis: As an indicator of the functional reserve of the liver Gastroenterol. Jpn. 24 1989 290-297
15. 99m -NGA functional hepatic imaging: Preliminary clinical experience J. Nucl. Med. 26 1985 1233-1242
16. M. Kudo D.R. Vera R.C. Stadalnik W.L. Trudeau K. Ikekubo A. Todo In vivo estimates of hepatic binding protein concentration: Correlation with classical indicators of hepatic functional reserve Am. J. Gastroenterol. 85 1990 1142-1148
17. M. Kudo A. Todo K. Ikekubo M. Hino Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage Am. J. Gastroenterol. 87 1992 865-870
18. T. Sawamura S. Kawasato M. Tsuda et al. Asialogylcoproteins to estimate residual liver function in patients with chronic liver disease with or without hepatocellular carcinoma Gastroenterol. Jpn. 20 1985 201-208
19. E. Kawamura S. Shiomi H. Ishizu et al. Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA Hepatol. Res. 27 2003 129-135
20. 99m galactosy1 serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patients outcome Hepatol. Res. 28 2004 184-190
21. 99m-GSA J. Nucl. Med. 38 1997 79-82
22. Y. Takahashi M. Shimizu Study Group of Fulminant Hepatitis An etiology and prognosis of fulminant viral hepatitis in Japan; a multicenter study J. Gastroenterol. Hepatol. 6 1991 159-164
23. 99mTc-galactosyl serum albumin KAKUIGAKU (Jpn. J. Nucl. Med.) 30 1993 1333-1339
24. 99m galactosyl-neoglycoalbumin: In vitro characterization of receptor-mediated binding J. Nucl. Med. 25 1984 779-787
25. T. Sawamura H. Nakada H. Hazama et al. Hyperasialoglycoproteinemia in patients with chronic liver disease and/or liver cell carcinoma Gastroenterology 87 1984 1217-1221
26. G. Paumgartner The handling of Indocyanine Green by the lixer Schweiz. Med. Wschr. 105 1975 1-30
27. T. Sawamura S. Kawasato M. Tsuda et al. Asialogylcoproteins to estimate residual liver function in patients with chronic liver disease with or without hepatocellular carcinoma Gastroenterol. Jpn. 20 1985 201-208
28. Yoshiba M, Sekiyama K, Inoue K, et al. Early diagnosis and treatment of fulminant hepatitis. Intractable Liver Diseases Study Group of Japan, The Ministry of Health of Welfare Annual Report at 1997. 1998. p. 75-8. (in Japanese)